Pei-Fang T.

Pei-Fang T. has a diverse work experience spanning multiple roles and companies. Starting in 2014, they worked at the National Institutes of Health as a Research Fellow Federal Agent, where they utilized cutting-edge techniques such as CRISPR-cas to modify genes and generate stable cell lines for drug testing. They also conducted single molecule RNA-FISH to study interchromosome regulation. In 2016, they transitioned to the role of Visiting Fellow at the same institution, focusing on the epigenetic role and regulatory mechanism of development in embryonic stem cells and muscle stem cells. They used CRISPR-cas and characterized enhancer RNA through single molecule RNA FISH and 3D DNA FISH. In 2018, Pei-Fang T. joined Fate Therapeutics Inc, where they have held positions as a Scientist, Senior Scientist, and currently, Principal Scientist. The specific responsibilities and contributions in these roles are not provided.

Pei-Fang T. attended the University of Pennsylvania from 2010 to 2013, where they studied Biochemistry, Biophysics, and Molecular Biology. Prior to that, they completed their undergraduate studies in Biochemistry and Molecular Biology at the University of California, Riverside from 2006 to 2009. Pei-Fang earned their initial degree in Biochemistry from National Taiwan University between 2001 and 2005. Pei-Fang T. has also obtained several additional certifications related to leadership, mindset development, and communication through LinkedIn in 2021.